A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Aurigene Discovery Technologies Limited
IDEAYA Biosciences
Orano Med LLC
OncoNano Medicine, Inc.
Calico Life Sciences LLC
M.D. Anderson Cancer Center
Leap Therapeutics, Inc.
H. Lee Moffitt Cancer Center and Research Institute
Lumos Pharma
Incyte Corporation
Emory University
Celgene
University of Louisville
Memorial Sloan Kettering Cancer Center
Rutgers, The State University of New Jersey
Cellectar Biosciences, Inc.
Bristol-Myers Squibb
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
BioCis Pharma Ltd
Pharmacyclics LLC.